Bone matrix derived from mandibular periosteal cells and cultivated by tissue engineering on a polymer fleece has recently been used for sinus floor elevation and augmentation. This case report focuses on clinical and histologic results after lateral ridge augmentation of a localized non-space maintaining defect in the right posterior area of the mandible using tissue-engineered bone. Implant supported prosthetic rehabilitation of a partially edentulous 32-year-old woman was planned involving a fixed partial denture. Preoperative investigations revealed a transversely reduced alveolar ridge width on the right side of the posterior mandible. Lateral augmentation was performed using tissue-engineered bone obtained by autogenous periosteum cells from the same area. Six months after augmentation 2 implants were placed and a bone biopsy was obtained from the augmented area. Transverse ridge dimensions were found to be enhanced. Histologic examination of the biopsy revealed dense lamellar bone. Wound healing was uneventful after all surgical interventions. This case report demonstrates the successful clinical application of tissue-engineered bone for lateral augmentation of the transversely reduced alveolar ridge. The results suggest that periosteum-derived tissue-engineered bone can be used to create a sufficient implant site not only for the sinus floor elevation and augmentation procedure for vertical bone enhancement but also for lateral augmentation.
Download full-text PDF |
Source |
---|
Colloids Surf B Biointerfaces
December 2024
Department of Orthopaedic Surgery, Orthopaedic Center, The First Hospital of Jilin University, Changchun 130021, China. Electronic address:
Large bone defects are a major clinical challenge in bone reconstructive surgery. 3D printing is a powerful technology that enables the manufacture of custom tissue-engineered scaffolds for bone regeneration. Electrical stimulation (ES) is a treatment method for external bone defects that compensates for damaged internal electrical signals and stimulates cell proliferation and differentiation.
View Article and Find Full Text PDFBioact Mater
April 2025
Zhanjiang Key Laboratory of Orthopaedic Technology and Trauma Treatment, Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Infectious Diseases, Guangdong Key Laboratory for Research and Development of Natural Drugs, School of Pharmacy, School of Ocean and Tropical Medicine, The Affiliated Hospital, The Second Affiliated Hospital, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, 524037, China.
Repair of osteoporotic bone defects (OBD) remains a clinical challenge due to dysregulated bone homeostasis, characterized by impaired osteogenesis and excessive osteoclast activity. While drug-loaded 3D-printed scaffolds hold great potential in the restoration of bone homeostasis for enhanced OBD repair, achieving the controlled release and targeted delivery of drugs in a 3D-printed scaffold is still unmet. Herein, we developed an electrostatic encapsulation strategy to motivate 3D-printed polyelectrolyte scaffolds (APS@P) with bone-targeting liposome formulation of salvianolic acid B (SAB-BTL).
View Article and Find Full Text PDFJ Cell Physiol
December 2024
Dental Research Center, Research Institute of Dental Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Incorporating autologous patient-derived products has become imperative to enhance the continually improving outcomes in bone tissue engineering. With this objective in mind, this study aimed to evaluate the osteogenic potential of 3D-printed allograft-alginate-gelatin scaffolds coated with stromal vascular fraction (SVF) and platelet-rich fibrin (PRF). The primary goal was to develop a tissue-engineered construct capable of facilitating efficient bone regeneration through the utilization of biomaterials with advantageous properties and patient-derived products.
View Article and Find Full Text PDFJ Orthop
February 2025
Department of Orthopaedics, University of KwaZulu Natal, South Africa.
Background: Osteogenic Bone Matrix (Altis™ OBM) is a tissue-engineered, porcine-derived demineralized bone matrix prepared using a humanization processing technology that confers biocompatibility and improved osteoinductivity. The objective of this study was to determine the safety and efficacy of OBM in patients with traumatic long bone defects in an open-label, non-randomized single-center study.
Methods: Diagnosis and main criteria for inclusion were open long bone fractures graded as Gustilo-Anderson Grade II, IIIA or IIIB.
World Neurosurg
December 2024
The Spinal Fusion Laboratory, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Objective: To (1) create a novel tissue-engineered bone graft comprising the osteoinductive oxysterol Oxy133 and (2) compare the osteogenic capability of this novel bone graft with bone graft substitutes previously examined.
Methods: Oxy133 was homogeneously incorporated into a biomimetic bone graft substitute (BioMim) comprising extracellular matrix and calcium phosphates. Two iterations of the graft were created: one corresponding to an implant-dose of 2.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!